SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K was filed on December 8, 2010, by India Globalization Capital, Inc. (also referenced as IGC Pharma, Inc. in metadata). The report covers the closing of a public offering of common stock and warrants on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of a capital event rather than a financial performance report.
Material Changes
The primary material event reported is the closing of a public offering of common stock and warrants. No comparative financial data or prior period changes are detailed in this specific filing.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, or contingencies are not included in the body of this Form 8-K. The filing references a press release (Exhibit 99.1) for further details regarding the offering.
Investor Verification Checklist
- Verify the total number of shares and warrants issued in the offering.
- Confirm the offering price per share and the total gross proceeds raised.
- Review the attached press release (Exhibit 99.1) for underwriting details and use of proceeds.
- Check subsequent filings for the impact of this capital raise on the company's balance sheet and cash position.